COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX)

Q4 2021 13F Holders as of 12/31/2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 87.8M
Number of holders: 17
Total 13F shares, excl. options: 1.33M
Shares change: +1.33M
Total reported value, excl. options: $8.44M
Value change: +$8.44M
Number of buys: 17
Price: $6.32

Significant Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) as of Q4 2021

17 filings reported holding CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q4 2021.
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.33M shares of 87.8M outstanding shares and own 1.52% of the company stock.
Largest 10 shareholders include Prosight Management, LP (302K shares), Nantahala Capital Management, LLC (210K shares), AMERICAN FINANCIAL GROUP INC (205K shares), P.A.W. CAPITAL CORP (100K shares), Kestra Advisory Services, LLC (95.1K shares), TWO SIGMA INVESTMENTS, LP (83.4K shares), TWO SIGMA ADVISERS, LP (68.9K shares), VANGUARD GROUP INC (58.6K shares), MILLENNIUM MANAGEMENT LLC (56.4K shares), and B. Riley Financial, Inc. (30.9K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.